PT Kalbe Farma Tbk - Company Profile
Powered by 
All the data and insights you need on PT Kalbe Farma Tbk in one report.
$295
- Save hours of research time and resources with
our up-to-date PT Kalbe Farma Tbk Strategy Report
- Understand PT Kalbe Farma Tbk position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
PT Kalbe Farma Tbk (Kalbe) provides healthcare solutions to its customers. The company focuses on the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products, and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products, supplements, and over-the-counter (OTC) drugs, energy drinks, and various other preventive products. Kalbe is involved in the marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceutical products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, the Philippines, and Singapore. The company serves hospitals, pharmacies, and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.
Headquarters
Indonesia
Address
Gedung Kalbe Let.Jend Suprato Kav. 4, Jakarta Pusat, Daerah Khusus Ibukota Jakarta Raya, 10510
Website
www.kalbe.co.id
Telephone
62 21 42873888
No of Employees
13,108
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
KLBF (JAK)
Revenue (2022)
$2.0B
5.2%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-18.2%
(2022 vs 2021)
Market Cap*
$4.3B
Net Profit Margin (2022)
XYZ
-22.2%
(2022 vs 2021)
* As of and is in US$
PT Kalbe Farma Tbk premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Over-The-Counter | Health Services | Brainact |
| Consumer Products | Medical Services | Broadced |
| Medical Devices | Animal Health Services | Cernevit |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In November, the company and Fapon Biotech signed a memorandum of understanding to deepen cooperation and boost Indonesia's IVD development. |
| 2023 | Contracts/Agreements | In September, PT Kalbe Genexine Biologics entered into an exclusive license agreement with Shanghai Henlius Biotech for the development and commercialisation of HANSIZHUANG (serplulimab injection). |
| 2023 | Corporate Changes/Expansions | In March, the company’s subsidiary PT Bintang Toedjoe, inaugurated a tissue culture laboratory called Kalbe Ubaya Hanbang-Bio (KUH). |
Competitor Comparison
| Key Parameters | PT Kalbe Farma Tbk | PT Tempo Scan Pacific Tbk | PT. Millennium Pharmacon International TBK | PT Prodia Widyahusada Tbk | PT Darya-Varia Laboratoria Tbk |
|---|---|---|---|---|---|
| Headquarters | Indonesia | Indonesia | Indonesia | Indonesia | Indonesia |
| City | Jakarta Pusat | Jakarta | Jakarta Selatan | Jakarta | Jakarta Selatan |
| State/Province | Daerah Khusus Ibukota Jakarta Raya | Daerah Khusus Ibukota Jakarta Raya | Daerah Khusus Ibukota Jakarta Raya | Daerah Khusus Ibukota Jakarta Raya | Jakarta |
| No. of Employees | 13,108 | 4,525 | 1,121 | 2,957 | 1,269 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Vidjongtius | President Director | Executive Board | 2017 | 58 |
| Bernadette Ruth Irawati Setiady | President Commissioner | Executive Board | 2017 | 61 |
| Bernadus Karmin Winata | Director | Senior Management | 2017 | 59 |
| Lukito Kurniawan Gozali | Secretary | Senior Management | 2018 | 44 |
| Sie Djohan | Director | Senior Management | 2017 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward